WebAddress: Byk-Gulden-Straße 25, Singen, 78224, DE Advertisement. Map Location: About the Business: Takeda is a Pharmaceutical company located at Byk-Gulden-Straße 25, Singen, 78224, DE. The business is listed under pharmaceutical company category. It has received 3 reviews with an average rating of 5 stars. WebOwned by: BYK-GULDEN LOMBERG, CHEMISCHE FABRIK GMBH Serial Number: 75008122. LINETTA. Filed: March 25, 1997 diagnostic preparations for medical use Owned by: BYK-GULDEN LOMBERG, CHEMISCHE FABRIK GMBH Serial Number: 75263694. ZURCAL. Filed: April 14, 1997 medicaments, namely, gastro-intestinal preparations
Patents Assigned to Byk Gulden - Justia Patents Search
WebByk Gulden Italia S.p.a. has not been involved in any trademark assignment transactions in the PlainSite database. Incoming Payments This individual has not disclosed any … WebByk-Gulden-Str. 2, 78467 Konstanz, Germany. Telephone Number : +49-7531/84-0. Fax Number : +49-7531/84-2474. Founded : 1873 . Takeda GmbH is a Takeda Group company. The Company has 1,700 employees and four sites in Germany, including two pharmaceutical production sites in Singen and Oranienburg. TOP. garden of eden arboretum and botanical garden
BYK Instruments - Overview, News & Competitors ZoomInfo.com
WebApr 25, 2003 · Patents Assigned to Byk Gulden Administration form comprising an acid-labile active compound. Patent number: 6884437 Abstract: Novel administration forms for acid-labile active compounds are described. The novel administration forms have no enteric layers and are suitable for oral administration. WebAltana, the West German parent of Byk-Gulden, is reorganizing its U.S. pharmaceutical operations under a newly-formed entity, the Byk Group, which will include E. Fougera, Pharmaderm and Savage Labs. The company announced the reorganization Sept. 25. The total U.S. business is further being consolidated into Altana Inc. That new corporation will … WebDuring 2000, Byk Gulden was carrying out phase III trials in the US and Europe and in March 2001, results were expected in the third quarter of 2001 [312399], [383726], [423659]. Two inhalant formulations (multidose powder and propellant filled) and a nasal formulation of ciclesonide are being developed by Byk Gulden for the treatment of asthma ... garden of eden back tattoo